Anvendelse av et progestin og L-arginin, en nitrogenoksiddonor eller begge, for fremstilling av et medikamentved behandling av preeklampsi og/eller for tidlige födselsveer hoset gravid hunnpattedyr

Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromb...

Full description

Saved in:
Bibliographic Details
Main Authors GARFIELD, ROBERT E, CHWALISZ, KRISTOF, YALLAMPALLI, CHANDRA, BUKOWSKI, RADOSLAW
Format Patent
LanguageNorwegian
Published 29.04.2002
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Preeclampsia and preterm labor in a pregnant female mammal are treated by administering thereto a combination of a progestin and a nitric oxide synthase substrate, a nitric oxide donor or both, optionally in further combination with one or more of a cyclooxygenase inhibitor, a PGI2-mimetic, a thromboxane (TXA2) inhibitor, a compound possessing TXA2-agonistic and TXA2-inhibiting properties, a compound possessing TXA2-antagonistic and PGI2-memetic activities, and a TXA2 antagonist.
Bibliography:Application Number: NO19960000169